Received Feb 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
had PHN for 18 months and decided to try the vaccine to stop the PHN; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of drug use for unapproved indication in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Concurrent medical conditions included post herpetic neuralgia (had PHN for 18 months). Concomitant products included gabapentin. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced drug use for unapproved indication (Verbatim: had PHN for 18 months and decided to try the vaccine to stop the PHN). The outcome of the drug use for unapproved indication was not applicable. Additional Information: GSK Receipt Date: 30-JAN-2026 This case was reported by a patient via interactive digital media. The patient mentioned that after vaccination PHN (post herpetic neuralgia) subsided slightly but did not go away. The patient was prescribed gabapentin, but the side effects were worse than the pain. He/she did not want to get shingles ever again. The batch number was not provided, and unable to contact the reporter.
Post herpetic neuralgia (had PHN for 18 months)
GABAPENTIN